Markets finish week down after bouncing on Bannon's exit >>> READ MORE

Top 6 Stocks to Buy for September

These stocks should weather the storms of political and economic instability

      View All  

Top Stock to Buy #1 – Celgene (CELG)

Celgene (CELG) develops small-molecule drugs for the treatment of blood-borne and solid-tumor cancers and inflammatory diseases. S&P said it has “the brightest growth prospects among large-cap biotech companies,” and the stock has been on the Trade of the Day buy list for over a year.

In early January, CELG broke from a classic cup-and-handle formation, which took the form of a wedge or right triangle. This has been followed by three more breaks and has run the stock from $78 to almost $150.

From the standpoint of technical analysis, it just doesn’t get better than this. The stock consolidates, pauses to gain new strength, and then breaks out again. And that is what it appears to be doing now with the recent jump from $133. The target for the current breakout is $155 and is supported by a strong new MACD buy signal.

CELG Chart
Click to Enlarge

Chart Key 

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC